Patients prescribed medical cannabis products overwhelmingly report improvements in their health-related quality of life, according to survey data compiled by the British medical cannabis provider Releaf. Researchers surveyed 1,669 adults medically authorised to consume cannabis. Most respondents suffered from either chronic pain or mental health issues. Respondents primarily consumed herbal cannabis, with about one-third of patients consuming CBD-dominant formulations.
Prior to consuming cannabis, 68% of respondents reported that their quality of life was “significantly impaired”. Following cannabis therapy, 88% reported “improved or significantly improved” quality of life. “This comprehensive survey of 1,669 active medical cannabis patients represents the largest study of prescribed medical cannabis users in the UK to date”, the study’s authors concluded. “The findings reveal a patient population experiencing transformative benefits from their treatment”.
21 November, 2025